ES2277546A1 - Microbial method for the production of specific isomers of conjugated linoleic acids - Google Patents
Microbial method for the production of specific isomers of conjugated linoleic acids Download PDFInfo
- Publication number
- ES2277546A1 ES2277546A1 ES200502849A ES200502849A ES2277546A1 ES 2277546 A1 ES2277546 A1 ES 2277546A1 ES 200502849 A ES200502849 A ES 200502849A ES 200502849 A ES200502849 A ES 200502849A ES 2277546 A1 ES2277546 A1 ES 2277546A1
- Authority
- ES
- Spain
- Prior art keywords
- conjugated linoleic
- trans
- isomer
- production
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940108924 conjugated linoleic acid Drugs 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000000813 microbial effect Effects 0.000 title abstract description 7
- 244000005700 microbiome Species 0.000 claims abstract description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 25
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 claims abstract description 24
- 235000021322 Vaccenic acid Nutrition 0.000 claims abstract description 24
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 claims abstract description 24
- 241000894006 Bacteria Species 0.000 claims abstract description 11
- 241000233866 Fungi Species 0.000 claims abstract description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 26
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 20
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 244000286779 Hansenula anomala Species 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 7
- 235000020778 linoleic acid Nutrition 0.000 claims description 7
- 239000002028 Biomass Substances 0.000 claims description 5
- 241000235646 Cyberlindnera jadinii Species 0.000 claims description 5
- 235000008429 bread Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 235000013618 yogurt Nutrition 0.000 claims description 4
- 235000014683 Hansenula anomala Nutrition 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims 4
- 238000012512 characterization method Methods 0.000 claims 2
- 241001149669 Hanseniaspora Species 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 9
- 239000001963 growth medium Substances 0.000 abstract description 5
- 238000010348 incorporation Methods 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 15
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 241000235070 Saccharomyces Species 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 241000894007 species Species 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 208000031439 Striae Distensae Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 208000005623 Carcinogenesis Diseases 0.000 description 4
- 241001468192 Leuconostoc citreum Species 0.000 description 4
- 230000036952 cancer formation Effects 0.000 description 4
- 231100000504 carcinogenesis Toxicity 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000186684 Lactobacillus pentosus Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 125000005313 fatty acid group Chemical group 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102100034543 Fatty acid desaturase 3 Human genes 0.000 description 2
- 108010087894 Fatty acid desaturases Proteins 0.000 description 2
- 240000000064 Penicillium roqueforti Species 0.000 description 2
- 241000588902 Zymomonas mobilis Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000004767 rumen Anatomy 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 244000253897 Saccharomyces delbrueckii Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A23L1/30—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Abstract
Description
Procedimiento microbiano de producción de isómeros específicos de ácidos linoleicos conjugados.Microbial production process of specific isomers of conjugated linoleic acids.
Esta invención se refiere a un procedimiento de producción de ácidos linoleicos conjugados, particularmente el isómero cis-9, trans-11, utilizando microorganismos. La utilización de dichos ácidos puede aplicarse a la bioalimentación y sector de la biotecnología.This invention relates to a method of production of conjugated linoleic acids, particularly the cis-9 isomer, trans-11, using microorganisms The use of these acids can be applied to the bio-food and biotechnology sector.
Con el nombre de ácidos linoleicos conjugados (abreviadamente CLAs por las siglas en inglés de conjugated linoleic acids) se suele hacer referencia a toda una colección de isómeros posicionales y geométricos de ácidos grasos poliinsaturados (abreviadamente PUFAs por las siglas en inglés de polyunsaturated fatty acids) con longitud de cadena de 18 átomos de carbono cuyos dobles enlaces, a diferencia del resto de PUFAs, están conjugados en la molécula al ocupar posiciones consecutivas.With the name of conjugated linoleic acids (abbreviated CLAs for the acronym in English of c onjugated l inoleic a cids), a whole collection of positional and geometric isomers of polyunsaturated fatty acids (abbreviated PUFAs) is usually referred to as p oly u nsaturated f atty a cids) with chain length of 18 carbon atoms whose double bonds, unlike the rest of PUFAs, are conjugated in the molecule by occupying consecutive positions.
El nombre que tienen los ácidos grasos con 18 átomos de carbono y dos dobles enlaces carbono=carbono es ácido octadecadienoico. De estas moléculas existen numerosos isómeros, tanto de posición de los dobles enlaces, denominados "isómeros de posición", como de la estereoquímica ("isómeros geométricos", cis o trans, Z o E). Entre todos ellos hay dos de importancia relevante. Se trata de los denominados cis-9, trans-11- y trans-10, cis-12-.The name that fatty acids have with 18 carbon atoms and two double bonds carbon = carbon is acidic octadecadienoic. Of these molecules there are numerous isomers, both position of the double bonds, called "isomers of position ", as of stereochemistry (" isomers geometric, "cis or trans, Z or E). Among them there are two of relevant importance It is the so-called cis-9, trans-11- and trans-10, cis-12-.
Las diferencias químicas entre el ácido linoleico y estos dos isómeros implican cambios drásticos en sus propiedades biológicas. En el caso de los CLAs se les atribuyen actividades funcionales de relevancia que pueden ser de radical interés para la industria agroalimentaria implicada en la producción de aditivos e ingredientes funcionales. Por ejemplo, se ha demostrado que los CLAs son capaces de actuar como agentes preventivos y terapéuticos en muchos modelos tumorales en animales de experimentación (Margot M et al. (2003). J. Mammary Gland Biol. Neoplas. 8: 103-118). Específicamente se ha demostrado la inhibición por CLAs de la inducción de carcinogénesis mamaria (Ip C et al. (1991). Cancer Res. 51: 6118-6124; Ip et al. (1997). Carcinogenesis 18: 755-759; Thompson H et al. (1997). Cancer Res. 57: 5067-5072; Ip C et al. Cancer Res. 54: 1212-1215; y Ip C et al. Nutr. Cancer 24: 149-157) y cáncer de colón en modelos de rata (Ha YL et al. (1990). Cancer Res. 50: 1097-1101; Park HS et al. (2001). Br. J. Nutr. 86: 549-555; y Liew C et al. (1995). Carcinogenesis 16: 3037-3043). Además se ha observado un efecto de CLAs en la reducción de tamaño y metástasis en modelos animales de cáncer de próstata, cáncer de pulmón y cáncer de mama. Utilizando modelos de cultivo in vitro de células cancerosas humanas se ha observado la inhibición de la proliferación tumoral usando el isómero cis-9-trans-11. Este isómero añadido en dieta es capaz por si sólo de reducir la aparición de carcinogénesis mamaria en ratas (Cori BA et al. (2003). J Nutr. 133: 2893-2900). Además, durante los últimos meses se han empezado a desentrañar los mecanismos moleculares responsables de todos estos efectos anticancerigenos (Chujo H et al. (2003). Cancer Lett. 202: 81-87; Kim KH et al. (2003). Nutrition 19: 772-777; Miller et al. (2003). Br. J. Nutr. 90: 877-885; Kemp MQ et al. (2003). J. Nutr. 133: 3670-3677; Chen BQ et al. (2003). World J Gastroenterol. 9: 1909-1914; Park HS et al. (2004). J. Nutr. Biochem. 15: 229-235; Tanmahasamut P et al. (2004). J. Nutr. 134: 674-680; y Nichenametla S et al. (2004). J. Toxicol. Environ. Health A 67: 469-481).The chemical differences between linoleic acid and these two isomers imply drastic changes in their biological properties. In the case of CLAs, relevant functional activities are attributed that may be of radical interest to the agri-food industry involved in the production of additives and functional ingredients. For example, CLAs have been shown to be able to act as preventive and therapeutic agents in many tumor models in experimental animals (Margot M et al . (2003). J. Mammary Gland Biol. Neoplas. 8 : 103-118) . Specifically, CLA inhibition of the induction of breast carcinogenesis has been demonstrated (Ip C et al . (1991). Cancer Res. 51 : 6118-6124; Ip et al . (1997). Carcinogenesis 18 : 755-759; Thompson H et al . (1997) Cancer Res. 57 : 5067-5072; Ip C et al . Cancer Res. 54 : 1212-1215; and Ip C et al . Nutr. Cancer 24 : 149-157) and colon cancer in rat models (Ha YL et al . (1990). Cancer Res. 50 : 1097-1101; Park HS et al . (2001). Br. J. Nutr. 86 : 549-555; and Liew C et al . ( 1995). Carcinogenesis 16 : 3037-3043). In addition, an effect of CLAs on the reduction of size and metastasis in animal models of prostate cancer, lung cancer and breast cancer has been observed. Using in vitro culture models of human cancer cells, tumor proliferation inhibition has been observed using the cis-9-trans-11 isomer. This isomer added in diet is capable of reducing the occurrence of breast carcinogenesis in rats (Cori BA et al . (2003). J Nutr. 133 : 2893-2900). In addition, during the last months the molecular mechanisms responsible for all these anticancer effects have begun to be unraveled (Chujo H et al . (2003). Cancer Lett. 202 : 81-87; Kim KH et al . (2003). Nutrition 19 : 772-777; Miller et al . (2003). Br. J. Nutr. 90 : 877-885; Kemp MQ et al . (2003). J. Nutr. 133 : 3670-3677; Chen BQ et al . ( 2003). World J Gastroenterol. 9 : 1909-1914; Park HS et al . (2004). J. Nutr. Biochem. 15 : 229-235; Tanmahasamut P et al . (2004). J. Nutr. 134: 674 -680; and Nichenametla S et al . (2004). J. Toxicol. Environ. Health A 67 : 469-481).
A todo ello hay que sumar otras actividades biológicas bien conocidas de los CLAs. La más explotada desde el punto de vista comercial hace referencia al hecho de que su ingesta en dieta reduce las reservas de grasa en ratas (Park Y et al. (1997). Lipids 32: 853-858; Delany JP et al. (1999). Am. J. Physiol. Regul. Integr. Comp. Physiol. 276: R1172-R1179; Tsuboyama N et al. (2000). Diabetes 49: 1534-1542; y Ohnuki K et al. (2001). Biosci. Biotechnol. Biochem. 65: 2200-2204.), ratones (Stang) GI. (2000). J. Nutr. 130: 1140-1146; Azain MJ et al. (2000). J. Nutr. 130: 1548-1554; Sugano M et al. (2001). Biosci. Biotechnol. Biochem. 65: 2535-2541; Poulos SP et al. (2001). J. Nutr. 131: 2722-2731; Sisk MB et al. (2001). J. Nutr. 131: 1668-1674; y Ealey KN et al. (2002). Lipids 37: 853-861), hamsters (de Deckere EA et al. (1999). Br. J. Nutr. 82: 309-317) y cerdos (Ostrowska E et al. (1999). J. Nutr. 129: 2037-2042; y Thiel-Cooper RL et al. (2001). J. Anim. Sci. 79: 1821-1828). Por ello se utiliza en la formulación de algunos preparados nutricionales con la idea de convertir grasa en músculo (dieta para deportistas) o perder peso sin perder músculo (dietas de adelgazamiento).To all this we must add other well-known biological activities of CLAs. The most commercially exploited refers to the fact that dietary intake reduces fat stores in rats (Park Y et al . (1997). Lipids 32 : 853-858; Delany JP et al . (1999 ) Am. J. Physiol. Regul. Integr. Comp. Physiol. 276 : R1172-R1179; Tsuboyama N et al . (2000). Diabetes 49 : 1534-1542; and Ohnuki K et al . (2001). Biosci. Biotechnol. Biochem. 65 : 2200-2204.), Mice (Stang) GI. (2000). J. Nutr. 130 : 1140-1146; Azain MJ et al . (2000). J. Nutr. 130 : 1548-1554; Sugano M et al . (2001). Biosci Biotechnol Biochem 65 : 2535-2541; Poulos SP et al . (2001). J. Nutr. 131 : 2722-2731; Sisk MB et al . (2001). J. Nutr. 131 : 1668-1674; and Ealey KN et al . (2002). Lipids 37 : 853-861), hamsters (from Deckere EA et al . (1999). Br. J. Nutr. 82 : 309-317) and pigs (Ostrowska E et al . (1999). J. Nutr. 129 : 2037-2042; and Thiel-Cooper RL et al . (2001). J. Anim. Sci. 79 : 1821-1828). Therefore, it is used in the formulation of some nutritional preparations with the idea of converting fat into muscle (diet for athletes) or losing weight without losing muscle (weight loss diets).
Otras propiedades de los CLAs hacen referencia a su capacidad para inhibir la aterogénesis en hamsters y conejos (de Deckere EA et al. (1999). Br. J. Nutr. 82: 309-317; Lee KN et al. (1994). Atherosclerosis 108: 19-25; Kritchevsky D et al. (2000). J. Am. Coll. Nutr. 19: 472S-477S; y Wilson TA et al. (2000). Nutr. Res. 20: 1795-1805, 32-34) y también, en ratas prediabéticas, a su capacidad para incrementar la sensibilidad a la insulina y mejorar la tolerancia a glucosa (Houseknecht KL et al. (1998). Biochem. Biophys. Res. Commun. 244: 678-682; y Ryder JW et al. (2001). Diabetes 50: 1149-1157). Sin embargo, dicho efecto es atribuible al isómero t-10-c-12 que induce esteatosis hepática, lo que desaconseja el uso del mismo (Clément L et al. (2002). J. Lipid Res. 43: 1400-1409).Other properties of CLAs refer to their ability to inhibit atherogenesis in hamsters and rabbits (from Deckere EA et al . (1999). Br. J. Nutr. 82 : 309-317; Lee KN et al . (1994). Atherosclerosis 108 : 19-25; Kritchevsky D et al . (2000). J. Am. Coll. Nutr. 19 : 472S-477S; and Wilson TA et al . (2000). Nutr. Res. 20 : 1795-1805, 32-34) and also, in pre-diabetic rats, their ability to increase insulin sensitivity and improve glucose tolerance (Houseknecht KL et al . (1998). Biochem. Biophys. Res. Commun. 244 : 678-682 ; and Ryder JW et al . (2001). Diabetes 50 : 1149-1157). However, this effect is attributable to the t-10-c-12 isomer that induces hepatic steatosis, which discourages its use (Clément L et al . (2002). J. Lipid Res. 43 : 1400-1409).
La fuente biológica natural de ácido linoleico son los aceites vegetales. Por el contrario, la fuente biológica natural de los CLAs son los productos lácteos y la carne de rumiantes. En realidad en este último caso es una bacteria del rumen quién produce los CLAs y los fija en el tejido del animal. Se comercializa un combinado de CLAs para la industria alimentaria (una mezcla isomolar de los dos isómeros con un 80% de pureza) y también se venden los isómeros puros aunque su precio es muy elevado, probablemente por la dificultad de purificación de ambos isómeros.The natural biological source of linoleic acid They are vegetable oils. On the contrary, the biological source CLAs' natural products are dairy and meat from ruminants Actually in the latter case it is a bacterium of rumen who produces the CLAs and fixes them on the animal's tissue. Be markets a combined CLAs for the food industry (an isomolar mixture of the two isomers with 80% purity) and pure isomers are also sold although their price is very high, probably due to the difficulty of purification of both isomers
Es posible sintetizar químicamente cada uno de los dos isómeros pero el proceso es complicado, caro y poco efectivo, de forma que tan sólo se obtiene un 50% de rendimiento con contaminaciones de los dos isómeros. Existen descripciones en la literatura que demuestran la posibilidad de utilizar la bacteria del rumen Butyvibrio fibrisolvens, o la enzima linoleoato isomerasa purificada desde la misma, para llevar a cabo una conversión enzimática de un ácido graso precursor en CLAs. También existen ejemplos sobre el uso de especies del género Lactobacillus o el empleo de lipasas de Candida cylindracea o Mucor miehei en la obtención selectiva de CLAs (Warvel, S; Borgdorf, R; Biotechnology Letters, 2000, 22: 1151-55), pero de nuevo todos estos procesos son poco efectivos.It is possible to chemically synthesize each of the two isomers but the process is complicated, expensive and ineffective, so that only 50% yield is obtained with contamination of the two isomers. There are descriptions in the literature that demonstrate the possibility of using the rumen bacterium Butyvibrio fibrisolvens , or the enzyme linoleoate isomerase purified from it, to carry out an enzymatic conversion of a precursor fatty acid into CLAs. There are also examples of the use of species of the genus Lactobacillus or the use of lipases from Candida cylindracea or Mucor miehei in the selective obtaining of CLAs (Warvel, S; Borgdorf, R; Biotechnology Letters, 2000, 22 : 1151-55), but Again, all these processes are ineffective.
Se ha descrito una forma de producir específicamente el isómero cis-9-trans-11, basada en crecer la levadura Saccharomyces cerevisiae modificada genéticamente (EUROSCARF) en presencia de ácido vaccénico (Patente española ES2204328-B) para que dicho ácido graso monosaturado se convierta específicamente en el isómero cis-9-trans-l1- gracias a la acción de una \Delta^{9}-desaturasa codificada en el genoma de este microorganismo. Es más, se ha descrito que en humanos la ingesta del isómero trans-11- del ácido vaccénico da lugar a su bioconversión en el isómero cis-9-trans-11- (Turpeinen et al. (2002). Am. J. Clin. Nutr. 76: 504-510).A way of specifically producing the cis-9-trans-11 isomer, based on growing the genetically modified Saccharomyces cerevisiae yeast (EUROSCARF) in the presence of vaccenic acid (Spanish patent ES2204328-B) so that said monosaturated fatty acid is converted, has been described. specifically in the cis-9-trans-l1- isomer thanks to the action of a Δ9-desaturase encoded in the genome of this microorganism. Moreover, it has been described that in humans the intake of the trans-11- isomer of vaccenic acid results in its bioconversion in the cis-9-trans-11- isomer (Turpeinen et al . (2002). Am. J. Clin Nutr. 76 : 504-510).
Por lo tanto, el problema técnico que se plantea es la producción específica del isómero cis-9, trans-11-, de forma eficaz, dada su probada utilidad biológica e inocuidad. En la presente invención se describen los ensayos de cinco cepas de bacterias, siete cepas de levaduras Saccharomyces cerevisiae, siete cepas de levaduras distintas de las Saccharomyces y dos especies de hongos, para evaluar su capacidad de producción del isómero cis-9, trans-11 del ácido linoleico conjugado, tanto en presencia como en ausencia de ácido vaccenico. Los resultados son un nuevo procedimiento de obtención del ácido cis-9, trans-11 del ácido linoleico conjugado.Therefore, the technical problem that arises is the specific production of the cis-9, trans-11- isomer, effectively, given its proven biological utility and safety. The present invention describes the tests of five strains of bacteria, seven strains of yeasts Saccharomyces cerevisiae , seven strains of yeasts other than Saccharomyces and two species of fungi, to evaluate their production capacity of the cis-9 isomer, trans-11 of conjugated linoleic acid, both in the presence and absence of vaccenic acid. The results are a new procedure for obtaining cis-9, trans-11 acid from conjugated linoleic acid.
La presente invención describe varios procedimientos para la producción específica del isómero cis-9-trans-11 del ácido linoleico conjugado. El primero de ellos describe la incorporación del isómero trans-11 del ácido vaccénico como sustrato a medios de cultivo donde crece una bacteria, una levadura o un hongo filamentoso y la bioconversión microbiana de dicho sustrato en el isómero de interés medida por la generación de un nuevo enlace de configuración Z (cis) en la posición 9 de la cadena. El segundo trata sobre la producción endógena por parte de algunos microorganismos del isómero cis9-trans11 sin que existan precursores en el medio de cultivo. Además se describe la producción constitutiva del isómero trans-11 del ácido vaccénico por parte de algunas levaduras.The present invention describes several procedures for the specific production of the isomer cis-9-trans-11 of conjugated linoleic acid. The first one describes the incorporation of the trans-11 acid isomer vaccenic as a substrate for culture media where a bacteria, a yeast or a filamentous fungus and bioconversion microbial of said substrate in the isomer of interest measured by the generation of a new configuration link Z (cis) in the position 9 of the chain. The second is about production endogenous by some microorganisms of the isomer cis9-trans11 without precursors in the culture medium. The constitutive production of the trans-11 isomer of vaccenic acid by some yeasts
La presente invención se basa en varios hechos relativos al metabolismo microbiano de los ácidos grasos. Así, la adición como sustrato del isómero trans-11 del ácido vaccénico a distintos microorganismos permite la producción de un ácido graso poliinsaturado (el isómero cis-9-trans-11 del ácido linoleico conjugado) con una insaturación adicional de configuración Z (cis) en la posición 9 de la cadena de dicho sustrato originada por la actuación de la enzima \Delta^{9}-desaturasa presente en todos los microorganismos ensayados. Aun más, determinados microorganismos son capaces de producir dicho isómero sin necesidad de sustrato precursor alguno al contener ácidos grasos (ácido vaccénico, ácido oléico u otros) en su citoplasma y/o membranas celulares que pueden actuar como sustratos de las actividades enzimáticas anteriormente mencionadas. En este sentido, se ha comprobado la producción constitutiva del isómero trans-11 del ácido vaccénico por parte de algunos microorganismos.The present invention is based on several facts related to the microbial metabolism of fatty acids. So, the addition as a substrate of the trans-11 isomer of vaccenic acid to different microorganisms allows the production of a polyunsaturated fatty acid (the isomer cis-9-trans-11 of conjugated linoleic acid) with additional unsaturation of configuration Z (cis) at position 9 of the chain of said substrate caused by the performance of the enzyme Δ 9 -desaturase present in all microorganisms tested. Even more, certain microorganisms they are capable of producing said isomer without substrate any precursor to contain fatty acids (vaccenic acid, acid oleic or others) in your cytoplasm and / or cell membranes that may act as substrates of enzyme activities above mentioned. In this sense, the production has been checked constitutive of the trans-11 acid isomer vaccenic by some microorganisms.
Sin que presuponga una limitación al ámbito de la aplicación de la presente invención tal y como se define en las presentes reivindicaciones, se describen a continuación ejemplos concretos de como llevar a cabo la invención.Without presupposing a limitation to the scope of the application of the present invention as defined in the present claims, examples are described below details of how to carry out the invention.
Ejemplo 1Example one
En la presente invención se han utilizado los microorganismos que se detallan en la tabla 1.In the present invention the microorganisms detailed in table 1.
El precrecimiento para la generación de colonias aisladas de bacterias de las especies Lactobacillus pentosus y Leuconostoc citreum se realizó en placas de medio sólido MRS-Agar inoculando una estría e incubando a 30°C durante 48 horas. Las colonias de las especies Bacillus subtilis y Escherichia coli se precrecieron en placas de medio sólido MC-Agar incubando a 30°C y 37°C respectivamente, durante 24 horas. Las colonias de la especie Zymomonas mobilis se crecieron en medio sólido YPD-Agar incubando a 30°C durante 48 horas. El precrecimiento de las levaduras del género Saccharomyces, así como de los géneros no-Saccharomyces, se realizó en placas de medio YPD-agar inoculando una estría de la suspensión microbiana e incubando a 30°C durante 48 horas. De forma similar, el precrecimiento de las colonias de hongos de las especies Aspergillus niger y Penicillium roqueforti se realizó en placas de medio sólido PDA incubando a 30°C y 19°C respectivamente, durante 6 días.Pre-growth for the generation of isolated colonies of bacteria of the Lactobacillus pentosus and Leuconostoc citreum species was performed on MRS-Agar solid medium plates inoculating a stretch mark and incubating at 30 ° C for 48 hours. Colonies of the species Bacillus subtilis and Escherichia coli were pre-grown on MC-Agar solid medium plates by incubating at 30 ° C and 37 ° C respectively, for 24 hours. Colonies of the species Zymomonas mobilis were grown in YPD-Agar solid medium by incubating at 30 ° C for 48 hours. The pre-growth of the yeasts of the Saccharomyces genus, as well as of the non- Saccharomyces genera, was performed on YPD-agar medium plates inoculating a stretch mark of the microbial suspension and incubating at 30 ° C for 48 hours. Similarly, the pre-growth of fungal colonies of the Aspergillus niger and Penicillium roqueforti species was carried out on PDA solid medium plates incubating at 30 ° C and 19 ° C respectively, for 6 days.
Para preparar el medio de inducción, 5 \mul de una solución etanólica 0,5 M del isómero trans-11 del ácido vaccénico se añadieron a 5 ml de medio líquido, usándose los mismos medios utilizados para la obtención de colonias o micelio pero sin agar y con la adición de tergitol al 1% v/v. De esta forma, el isómero trans-11 del ácido vaccénico se encontraba a una concentración final de 0,5 mM. La mezcla se inoculó con una colonia aislada del microorganismo en cuestión y se incubó durante 48 horas a la temperatura correspondiente en cada caso y con una agitación de 200 rpm, a excepción de la cepa de Leuconostoc citreum que se incubó sin agitación.To prepare the induction medium, 5 µl of a 0.5 M ethanol solution of the trans-11 isomer of the vaccenic acid was added to 5 ml of liquid medium, using the same means used to obtain colonies or mycelium but without agar and with the addition of 1% v / v tergitol. Thus, the trans-11 isomer of vaccenic acid was at a final concentration of 0.5 mM. The mixture was inoculated with a colony isolated from the microorganism in question and incubated for 48 hours at the corresponding temperature in each case and with a stirring of 200 rpm, with the exception of the Leuconostoc citreum strain that was incubated without stirring.
El cultivo se trasvasó a un tubo de 10 ml y se centrifugó a 4000 rpm durante 5 minutos. Se eliminó el sobrenadante y las células se resuspendieron en 1.5 ml de agua destilada y la suspensión se transfirió a un vial tipo eppendorf de 2 ml. Se centrifugó el cultivo en las mismas condiciones, repitiéndose otra vez la operación de lavado con el mismo volumen de agua destilada. Finalmente se centrifugó a 5000 rpm durante 5 minutos para eliminar totalmente el agua. A las células obtenidas se les añadió 1 ml de CHCl_{3}:MeOH (2:1) y la mezcla se dejó en incubación durante 1 hora. Finalmente, se centrifugó a 13200 rpm durante 15 segundos y se pasó el extracto orgánico a un nuevo vial de 2 ml donde se evaporó el disolvente.The culture was transferred to a 10 ml tube and centrifuged at 4000 rpm for 5 minutes. The supernatant was removed and the cells were resuspended in 1.5 ml of distilled water and the suspension was transferred to a 2 ml eppendorf vial. Be centrifuged the culture under the same conditions, repeating another Once the washing operation with the same volume of distilled water. It was finally centrifuged at 5000 rpm for 5 minutes to remove totally water. To the cells obtained 1 ml of CHCl3: MeOH (2: 1) and the mixture was allowed to incubate for 1 hour. Finally, it was centrifuged at 13200 rpm for 15 seconds and the organic extract was transferred to a new 2 ml vial where evaporated the solvent.
El residuo de ácidos grasos se metiló por adición de 500 \mul de una disolución 0.5 N de KOH en MeOH, seguido de neutralización después de 30 minutos con 500 \mul de HCI 1 N y extracción con 500 \mul de hexano. La capa orgánica se separó y se concentró hasta un volumen aproximado de 20 \mul.The fatty acid residue was methylmed by adding 500 µL of a 0.5 N solution of KOH in MeOH, followed by neutralization after 30 minutes with 500 µl of 1 N HCI and extraction with 500 µl hexane. The organic layer is separated and concentrated to an approximate volume of 20 µl.
A continuación se analizó el isómero cis-9-trans-11 del ácido linoleico conjugado. El éster metílico se analizó por cromatografía de gases-espectrometria de masas (CG-EM) en una columna apolar HP-VOC (0.2 mm*30 m*1.12 \mum) con el siguiente programa de temperaturas: 80°C (0 min.); 2.5°C/min hasta 220°C (0 min.); 2.0°C/min. hasta 260°C (15 min.).The isomer was then analyzed cis-9-trans-11 of conjugated linoleic acid. The methyl ester was analyzed by gas chromatography-mass spectrometry (CG-EM) on an HP-VOC apolar column (0.2 mm * 30 m * 1.12 \ mum) with the following program of temperatures: 80 ° C (0 min.); 2.5 ° C / min up to 220 ° C (0 min.); 2.0 ° C / min up to 260 ° C (15 min.).
Como se indica en la tabla 2, en todos los microorganismos se produjo en mayor o menor medida el isómero cis-9-trans-11- del ácido linoleico conjugado. En el caso de las bacterias B. subtilis y L. pentosus se detectaron producciones similares a las obtenidas en algunas levaduras del género Saccharomyces, mientras que en el resto de especies bacterianas la producción fue mucho menor. En el caso de los hongos filamentosos, la producción del isómero cis-9-trans-11- fue baja. Por el contrario, en todas las especies levaduriformes no-Saccharomyces analizadas, excepto en el caso de T. delbrueckii, se detectaron elevados niveles de producción, particularmente en el caso de las especies P. anomala, P. jadinii y H. guillermondii.As indicated in Table 2, in all microorganisms the cis-9-trans-11- isomer of conjugated linoleic acid was produced to a greater or lesser extent. In the case of B. subtilis and L. pentosus bacteria, similar productions to those obtained in some yeasts of the Saccharomyces genus were detected, while in the rest of bacterial species the production was much lower. In the case of filamentous fungi, the production of the cis-9-trans-11- isomer was low. On the contrary, in all the non- Saccharomyces levaduriform species analyzed, except in the case of T. delbrueckii , high levels of production were detected, particularly in the case of P. anomala, P. jadinii and H. guillermondii species.
Ejemplo 2Example 2
Como en el ejemplo anterior, se utilizaron los microorganismos que se detallan en la tabla 1.As in the previous example, the microorganisms detailed in table 1.
El precrecimiento para la generación de colonias aisladas de bacterias de las especies Lactobacillus pentosus y Leuconostoc citreum se realizó en placas de medio sólido MRS-Agar inoculando una estría e incubando a 30°C durante 48 horas. Las colonias de las especies Bacillus subtilis y Escherichia coli se precrecieron en placas de medio sólido MC-Agar incubando a 30°C y 37°C respectivamente, durante 24 horas. Las colonias de la especie Zymomonas mobilis se crecieron en medio sólido YPD-Agar incubando a 30°C durante 48 horas. El precrecimiento de las levaduras del género Saccharomyces, así como de los géneros no-Saccharomyces, se realizó en placas de medio YPD-agar inoculando una estría de la suspensión microbiana e incubando a 30°C durante 48 horas. De forma similar, el precrecimiento de las colonias de hongos de las especies Aspergillus niger y Penicillium roqueforti se realizó en placas de medio sólido PDA incubando a 30°C y 19°C respectivamente, durante 6 días.Pre-growth for the generation of isolated colonies of bacteria of the Lactobacillus pentosus and Leuconostoc citreum species was performed on MRS-Agar solid medium plates inoculating a stretch mark and incubating at 30 ° C for 48 hours. Colonies of the species Bacillus subtilis and Escherichia coli were pre-grown on MC-Agar solid medium plates by incubating at 30 ° C and 37 ° C respectively, for 24 hours. Colonies of the species Zymomonas mobilis were grown in YPD-Agar solid medium by incubating at 30 ° C for 48 hours. The pre-growth of the yeasts of the Saccharomyces genus, as well as of the non- Saccharomyces genera, was performed on YPD-agar medium plates inoculating a stretch mark of the microbial suspension and incubating at 30 ° C for 48 hours. Similarly, the pre-growth of fungal colonies of the Aspergillus niger and Penicillium roqueforti species was carried out on PDA solid medium plates incubating at 30 ° C and 19 ° C respectively, for 6 days.
Una colonia aislada del microorganismo en cuestión se inoculó en 5 ml de medio líquido con tergitol al 1% (v/v) y la mezcla se incubó durante 48 horas a la temperatura correspondiente para cada microorganismo y con una agitación de 200 rpm, a excepción de la cepa de Leuconostoc citreum que se incubó sin agitación.A colony isolated from the microorganism in question was inoculated in 5 ml of liquid medium with 1% tergitol (v / v) and the mixture was incubated for 48 hours at the corresponding temperature for each microorganism and with a stirring of 200 rpm, except of the Leuconostoc citreum strain that was incubated without agitation.
El cultivo se trasvasó a un tubo de 10 ml y se centrifugó a 4000 rpm durante 5 minutos. Se eliminó el sobrenadante y las células se resuspendieron en 1.5 ml de agua destilada y la suspensión se transfirió a un vial tipo eppendorf de 2 ml. Se centrifugó el cultivo en las mismas condiciones, repitiéndose otra vez la operación de lavado con el mismo volumen de agua destilada. Finalmente se centrifugó a 5000 rpm durante 5 minutos para eliminar totalmente el agua. A las células obtenidas se les añadió 1 ml de CHCl_{3}:MeOH (2:1) y la mezcla se dejó en incubación durante 1 hora. Finalmente, se centrifugó a 13200 rpm durante 15 segundos y se pasó el extracto orgánico a un nuevo vial de 2 ml donde se evaporó el disolvente.The culture was transferred to a 10 ml tube and centrifuged at 4000 rpm for 5 minutes. The supernatant was removed and the cells were resuspended in 1.5 ml of distilled water and the suspension was transferred to a 2 ml eppendorf vial. Be centrifuged the culture under the same conditions, repeating another Once the washing operation with the same volume of distilled water. It was finally centrifuged at 5000 rpm for 5 minutes to remove totally water. To the cells obtained 1 ml of CHCl3: MeOH (2: 1) and the mixture was allowed to incubate for 1 hour. Finally, it was centrifuged at 13200 rpm for 15 seconds and the organic extract was transferred to a new 2 ml vial where evaporated the solvent.
El residuo de ácidos grasos se metiló por adición de 500 \mul de una disolución 0.5 N de KOH en MeOH, seguido de neutralización después de 30 minutos con 500 \mul de HCI 1 N y extracción con 500 \mul de hexano. La capa orgánica se separó y se concentró hasta un volumen aproximado de 20 \mul.The fatty acid residue was methylmed by adding 500 µL of a 0.5 N solution of KOH in MeOH, followed by neutralization after 30 minutes with 500 µl of 1 N HCI and extraction with 500 µl hexane. The organic layer is separated and concentrated to an approximate volume of 20 µl.
A continuación se analizó el isómero cis-9-trans-11 del ácido linoleico conjugado. El éster metílico se analizó por cromatografía de gases-espectrometría de masas (CG-EM) en una columna apolar HP-VOC (0.2 mm*30 m*1.12 \mum) con el siguiente programa de temperaturas: 80°C (0 min.); 2.5°C/min hasta 220°C (0 min.); 2.0°C/min. hasta 260°C (15 min.).The isomer was then analyzed cis-9-trans-11 of conjugated linoleic acid. The methyl ester was analyzed by gas chromatography-mass spectrometry (CG-EM) on an HP-VOC apolar column (0.2 mm * 30 m * 1.12 \ mum) with the following program of temperatures: 80 ° C (0 min.); 2.5 ° C / min up to 220 ° C (0 min.); 2.0 ° C / min up to 260 ° C (15 min.).
Dadas las elevadas producciones del isómero cis-9-trans-11 detectadas en algunos de los microorganismos ensayados en el ejemplo anterior, sobretodo P. anomala y P. jadinii que producen más isómero (0,9748 mM y 0,6077 mM, respectivamente) que la cantidad de sustrato precursor trans-11 del ácido vaccénico adicionado (0.5 mM), se decidió ensayar la posible síntesis endógena de novo por parte de los microorganismos analizados. Para ello se crecieron en las mismas condiciones que en el ejemplo anterior pero sin el isómero trans-11 del ácido vaccénico en la formulación del medio.Given the high productions of the cis-9-trans-11 isomer detected in some of the microorganisms tested in the previous example, especially P. anomala and P. jadinii that produce more isomer (0.9748 mM and 0.6077 mM, respectively) that the amount of trans-11 precursor substrate of the added vaccenic acid (0.5 mM), it was decided to test the possible endogenous de novo synthesis by the microorganisms analyzed. For this, they were grown under the same conditions as in the previous example but without the trans-11 isomer of the vaccenic acid in the medium formulation.
Los resultados obtenidos se recogen en la tabla 3 e indican que tan sólo H. guillermondii y las especies del género Pichia analizadas en el experimento producen el isómero cis-9-trans-11 a niveles de relevancia, especialmente en el caso de P. anomala y P. jadinii. El resto de cepas ensayadas tiene unas producciones residuales del isómero en cuestión.The results obtained are shown in table 3 and indicate that only H. guillermondii and the species of the genus Pichia analyzed in the experiment produce the cis-9-trans-11 isomer at levels of relevance, especially in the case of P. anomala and P. jadinii . The rest of the strains tested have residual productions of the isomer in question.
Ejemplo 3Example 3
Se utilizaron las cepas S. cerevisiae CECT 1176 y Pichia anomala CECT 10590 (tabla 1).Strains S. cerevisiae CECT 1176 and Pichia anomala CECT 10590 (table 1) were used.
El precrecimiento de las levaduras se realizó en placas de medio YPD-agar inoculando una estría de la suspensión microbiana e incubando a 30°C durante 48 horas. Una colonia aislada del microorganismo en cuestión se inoculó en 5 ml de medio líquido YPD con tergitol al 1% (v/v). La mezcla se incubó durante 48 horas a la temperatura correspondiente para cada microorganismo con una agitación de 200 rpm.Yeast pre-growth was performed in YPD-agar media plates inoculating a stretch mark the microbial suspension and incubating at 30 ° C for 48 hours. A colony isolated from the microorganism in question was inoculated in 5 ml of YPD liquid medium with 1% tergitol (v / v). The mixture was incubated. for 48 hours at the corresponding temperature for each microorganism with a stirring of 200 rpm.
El cultivo se trasvasó a un tubo de 10 ml y se centrifugó a 4000 rpm durante 5 minutos. Se eliminó el sobrenadante y las células se resuspendieron en 1.5 ml de agua destilada y la suspensión se transfirió a un vial tipo eppendorf de 2 ml. Se centrifugó el cultivo en las mismas condiciones, repitiéndose otra vez la operación de lavado con el mismo volumen de agua destilada. Finalmente se centrifugó a 5000 rpm durante 5 minutos para eliminar totalmente el agua. A las células obtenidas se les añadió 1 ml de CHCl_{3}:MeOH (2:1) y la mezcla se dejó en incubación durante 1 hora. Finalmente, se centrifugó a 13200 rpm durante 15 segundos y se pasó el extracto orgánico a un nuevo vial de 2 ml donde se evaporó el disolvente.The culture was transferred to a 10 ml tube and centrifuged at 4000 rpm for 5 minutes. The supernatant was removed and the cells were resuspended in 1.5 ml of distilled water and the suspension was transferred to a 2 ml eppendorf vial. Be centrifuged the culture under the same conditions, repeating another Once the washing operation with the same volume of distilled water. It was finally centrifuged at 5000 rpm for 5 minutes to remove totally water. To the cells obtained 1 ml of CHCl3: MeOH (2: 1) and the mixture was allowed to incubate for 1 hour. Finally, it was centrifuged at 13200 rpm for 15 seconds and the organic extract was transferred to a new 2 ml vial where evaporated the solvent.
El residuo de ácidos grasos se metiló por adición de 500 \mul de una disolución 0.5 N de KOH en MeOH, seguido de neutralización después de 30 minutos con 500 \mul de HCl 1 N y extracción con 500 \mul de hexano. La capa orgánica se separó y se concentró hasta un volumen aproximado de 20 \mul.The fatty acid residue was methylmed by adding 500 µL of a 0.5 N solution of KOH in MeOH, followed by neutralization after 30 minutes with 500 µl of 1 N HCl and extraction with 500 µl hexane. The organic layer is separated and concentrated to an approximate volume of 20 µl.
A continuación se analizó el isómero trans-11 del ácido vaccénico. El éster metílico se analizó por cromatografía de gases-espectrometría de masas (CG-EM) en una columna apolar HP-VOC (0.2 mm*30 m*1.12 \mum) con el siguiente programa de temperaturas: 80°C (0 min.); 2.5°C/min hasta 220°C (0 min.); 2.0°C/min. hasta 260°C (15 min.).The isomer was then analyzed trans-11 of vaccenic acid. The methyl ester is analyzed by gas chromatography-spectrometry of masses (GC-MS) in a nonpolar column HP-VOC (0.2 mm * 30 m * 1.12 \ mum) with the following temperature program: 80 ° C (0 min.); 2.5 ° C / min up to 220 ° C (0 min.); 2.0 ° C / min up to 260 ° C (15 min.).
La tabla 4 muestra los resultados obtenidos. Como se puede observar, la levadura S. cerevisiae CECT 1176 produce una cantidad residual del isómero isómero trans-11 del ácido vaccénico. Por el contrario, la levadura P. anomala CECT 10590 produce aproximadamente 0,5 mM de dicho compuesto, definiendo unas condiciones de cultivo para la producción de este compuesto con posible actividad como ingrediente funcional. En cualquier caso, estos resultados sugieren que la producción del isómero 9-cis, 11-trans- de ácidos linoleicos conjugados por los microorganismos de la Tabla 1 se debe a que dichos microorganismos son en mayor o menor medida productores del ácido 11-trans-vaccénico.Table 4 shows the results obtained. As can be seen, yeast S. cerevisiae CECT 1176 produces a residual amount of the trans-11 isomeric isomer of vaccenic acid. In contrast, P. anomala CECT 10590 yeast produces approximately 0.5 mM of said compound, defining culture conditions for the production of this compound with possible activity as a functional ingredient. In any case, these results suggest that the production of the 9-cis, 11-trans- isomer of linoleic acids conjugated by the microorganisms of Table 1 is due to the fact that said microorganisms are, to a greater or lesser extent, producers of 11-trans- acid. vaccenic
En experimentos preliminares se ha llevado a cabo un procedimiento de producción de biomasa de levadura panadera cargada con el isómero cis-9-trans-11 del ácido linoleico conjugado Para ello se ha crecido la levadura Saccharomyces cerevisiae CECT 1326 en un fermentador de 300 litros conteniendo 200 litros de medio rico con melazas como fuente de carbono y el isómero trans-11 del ácido vaccénico a una concentración 0.5 mM. Las condiciones de fermentación fueron una temperatura de 30°C con agitación durante 24 horas. Pasado este tiempo se recogió por centrifugación la biomasa levaduriforme enriquecida en el isómero cis-9-trans-11 que se lavó dos veces por resuspensión en tampón fosfato sódico 50 mM pH 6.8 y posterior centrifugación. La pasta de biomasa resultante se caracterizó en cuanto a su contenido en el isómero cis-9-trans-11 del ácido linoleico conjugado, determinándose una concentración de 0,16 mM. Con dichas levaduras se fabricó pan en un horno piloto siguiendo un protocolo industrial establecido. Sobre los panes producidos se evaluó la concentración del isómero cis-9-trans-11 del ácido linoleico que fue de 0,35 \mug/gramo de pan.In preliminary experiments, a process for the production of baker's yeast biomass loaded with the cis-9-trans-11 isomer of conjugated linoleic acid has been carried out. Saccharomyces cerevisiae CECT 1326 yeast has been grown in a 300-liter fermenter containing 200 liters of rich medium with molasses as a source of carbon and the trans-11 isomer of vaccenic acid at a concentration of 0.5 mM. The fermentation conditions were a temperature of 30 ° C with stirring for 24 hours. After this time, the yeast-rich biomass enriched in the cis-9-trans-11 isomer was collected by centrifugation, which was washed twice by resuspension in 50 mM sodium phosphate buffer pH 6.8 and subsequent centrifugation. The resulting biomass pulp was characterized in terms of its content in the cis-9-trans-11 isomer of conjugated linoleic acid, determining a concentration of 0.16 mM. With these yeasts, bread was manufactured in a pilot oven following an established industrial protocol. The concentration of the cis-9-trans-11 isomer of the linoleic acid was evaluated on the breads produced, which was 0.35 µg / gram of bread.
Siguiendo una metodología similar se ha llevado a cabo un procedimiento de producción de yogur enriquecido en ácidos linoleicos conjugados, caracterizado porque consiste en añadir al medio de crecimiento de las bacterias ácido lácticas correspondientes el isómero trans-11 del ácido vaccénico. También se han llevado a cabo producciones industriales de embutidos curados utilizando iniciadores de fermentación (bacterias ácido lácticas) cargadas con el isómero cis-9-trans-11 del ácido linoleico conjugado mediante precrecimiento en medios con el isómero trans-11 del ácido vaccénico.Following a similar methodology has been carried carried out a procedure for the production of yogurt enriched in conjugated linoleic acids, characterized in that it consists of add to the growth medium of lactic acid bacteria corresponding the trans-11 isomer of the acid vaccenic Industrial productions have also been carried out of sausages cured using fermentation initiators (lactic acid bacteria) loaded with the isomer cis-9-trans-11 of conjugated linoleic acid by pre-growth in media with the trans-11 isomer of vaccenic acid.
Claims (7)
- a)to)
- incubación de un microorganismo productor de ácidos linoleicos conjugados, a elegir del grupo que consiste en bacterias, levaduras y hongos, preferiblemente levaduras no Saccharomyces, en medio líquido; yincubation of a microorganism producing conjugated linoleic acids, to be chosen from the group consisting of bacteria, yeasts and fungi, preferably non- Saccharomyces yeasts, in liquid medium; Y
- b)b)
- extracción de los ácidos linoleicos conjugados resultantes de la incubación de la etapa a); purificación y caracterización de dichos ácidos.linoleic acid extraction conjugates resulting from the incubation of step a); purification and characterization of said acids.
- a)to)
- incubación de un microorganismo productor de ácidos linoleicos conjugados, a elegir del grupo que consiste en bacterias, levaduras y hongos, preferiblemente levaduras no Saccharomyces, en medio líquido, en presencia de ácido vaccenico; yincubation of a microorganism producing conjugated linoleic acids, to be chosen from the group consisting of bacteria, yeasts and fungi, preferably non- Saccharomyces yeasts, in liquid medium, in the presence of vaccenic acid; Y
- b)b)
- extracción de los ácidos linoleicos conjugados resultantes de la incubación de la etapa a); purificación y caracterización de dichos ácidos.linoleic acid extraction conjugates resulting from the incubation of step a); purification and characterization of said acids.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502849A ES2277546B1 (en) | 2005-11-21 | 2005-11-21 | MICROBIAL PROCEDURE FOR THE PRODUCTION OF SPECIFIC ISOMEROS OF CONJUGATED LINOLEIC ACIDS. |
PCT/ES2006/000638 WO2007071800A1 (en) | 2005-11-21 | 2006-11-17 | Microbial method for the production of specific isomers of conjugated linoleic acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502849A ES2277546B1 (en) | 2005-11-21 | 2005-11-21 | MICROBIAL PROCEDURE FOR THE PRODUCTION OF SPECIFIC ISOMEROS OF CONJUGATED LINOLEIC ACIDS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2277546A1 true ES2277546A1 (en) | 2007-07-01 |
ES2277546B1 ES2277546B1 (en) | 2008-06-16 |
Family
ID=38188295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200502849A Expired - Fee Related ES2277546B1 (en) | 2005-11-21 | 2005-11-21 | MICROBIAL PROCEDURE FOR THE PRODUCTION OF SPECIFIC ISOMEROS OF CONJUGATED LINOLEIC ACIDS. |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2277546B1 (en) |
WO (1) | WO2007071800A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200811182A (en) | 2006-05-25 | 2008-03-01 | Wyeth Corp | Oxindoledioxans, synthesis thereof, and intermediates thereto |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997037546A1 (en) * | 1996-04-11 | 1997-10-16 | Loders Croklaan B.V. | Free flowing fat compositions |
WO1999029886A1 (en) * | 1997-12-05 | 1999-06-17 | Bjoerck Lennart | Formation of conjugated unsaturated fatty acids |
WO2001036653A1 (en) * | 1999-11-19 | 2001-05-25 | Valio Ltd | Method for preparing conjugated linoleic acid |
WO2003080850A1 (en) * | 2002-03-27 | 2003-10-02 | Valio Ltd | Process for preparing conjugated linoleic acid |
ES2204328A1 (en) * | 2002-10-04 | 2004-04-16 | Consejo Sup. De Invest. Cientificas | Method of producing polyunsaturated fatty acids with yeasts through the incorporation of olefinic or acetylenic substrates |
EP1500706A1 (en) * | 2002-04-12 | 2005-01-26 | Kabushiki Kaisha Yakult Honsha | Process for producing conjugated fatty acid and food/drink obtained by the process |
-
2005
- 2005-11-21 ES ES200502849A patent/ES2277546B1/en not_active Expired - Fee Related
-
2006
- 2006-11-17 WO PCT/ES2006/000638 patent/WO2007071800A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997037546A1 (en) * | 1996-04-11 | 1997-10-16 | Loders Croklaan B.V. | Free flowing fat compositions |
WO1999029886A1 (en) * | 1997-12-05 | 1999-06-17 | Bjoerck Lennart | Formation of conjugated unsaturated fatty acids |
WO2001036653A1 (en) * | 1999-11-19 | 2001-05-25 | Valio Ltd | Method for preparing conjugated linoleic acid |
WO2003080850A1 (en) * | 2002-03-27 | 2003-10-02 | Valio Ltd | Process for preparing conjugated linoleic acid |
EP1500706A1 (en) * | 2002-04-12 | 2005-01-26 | Kabushiki Kaisha Yakult Honsha | Process for producing conjugated fatty acid and food/drink obtained by the process |
ES2204328A1 (en) * | 2002-10-04 | 2004-04-16 | Consejo Sup. De Invest. Cientificas | Method of producing polyunsaturated fatty acids with yeasts through the incorporation of olefinic or acetylenic substrates |
Also Published As
Publication number | Publication date |
---|---|
ES2277546B1 (en) | 2008-06-16 |
WO2007071800A1 (en) | 2007-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ratledge | Fatty acid biosynthesis in microorganisms being used for single cell oil production | |
Wada et al. | Temperature-induced changes in the fatty acid composition of the cyanobacterium, Synechocystis PCC6803 | |
US5856149A (en) | Method of producing conjugated fatty acids | |
Kishino et al. | Ricinoleic acid and castor oil as substrates for conjugated linoleic acid production by washed cells of Lactobacillus plantarum | |
Ando et al. | Conjugated linoleic acid production from castor oil by Lactobacillus plantarum JCM 1551 | |
Wild et al. | Chemical composition and nutritional characteristics for ruminants of the microalgae Chlorella vulgaris obtained using different cultivation conditions | |
Akpinar-Bayizit | Fungal lipids: the biochemistry of lipid accumulation | |
ES2311060T3 (en) | ISOMERASA OF THE CONJUGATED LYNOLIC ACID AND A PROCESS FOR THE PRODUCTION OF THE CONJUGATED LYLOLEIC ACID. | |
Kamoun et al. | Fusarium verticillioides as a single-cell oil source for biodiesel production and dietary supplements | |
Barsanti et al. | Fatty acid content in wild type and WZSL mutant of Euglena gracilis | |
Miao et al. | Enzyme-catalysed synthesis of plant steryl laurate in non-aqueous media using salt hydrate pairs and its characterisation | |
Ratledge | Microorganisms as sources of polyunsaturated fatty acids | |
Dedyukhina et al. | Biosynthesis of arachidonic acid by micromycetes | |
Jeennor et al. | Comparative fatty acid profiling of Mucor rouxii under different stress conditions | |
Ashtiani et al. | Effect of mixed culture of yeast and microalgae on acetyl-CoA carboxylase and Glycerol-3-phosphate acyltransferase expression | |
Gurovic et al. | Lactic acid bacteria isolated from fish gut produce conjugated linoleic acid without the addition of exogenous substrate | |
JP4510203B2 (en) | Acquisition of γ-linolenic acid from the protozoan genus Colpidium | |
ES2277546B1 (en) | MICROBIAL PROCEDURE FOR THE PRODUCTION OF SPECIFIC ISOMEROS OF CONJUGATED LINOLEIC ACIDS. | |
Park et al. | Production of conjugated linoleic acid (CLA) by Bifidobacterium breve LMC520 and its compatibility with CLA-producing rumen bacteria | |
FI115842B (en) | Process for the preparation of conjugated linoleic acid | |
Ruiz et al. | Lipid content and fatty acid composition of a marine-derived Trichoderma longibrachiatum strain cultured by agar surface and submerged fermentations | |
Salunkhe et al. | Halomonas sp. nov., an EPA-producing mesophilic marine isolate from the Indian Ocean | |
JP2007129973A (en) | Method for producing unsaturated fatty acid-containing phospholipid | |
Nawal et al. | An overview of bacterial lipases and their enormous applications | |
Fiorino et al. | Triacylglycerols hydrolysis and hydroxy-and epoxy-fatty acids release during lactic fermentation of plant matrices: An extensive study showing inter-and intra-species capabilities of lactic acid bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20070701 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2277546B1 Country of ref document: ES |
|
PC2A | Transfer of patent |
Owner name: NATUREX, S.A. Effective date: 20120612 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180924 |